H1B Report
H-1B sponsorNYFEIN 20-1420845Updated Jul 2026

INVAGEN PHARMACEUTICALS, INC.

US H-1B Labor Condition Application activity for INVAGEN PHARMACEUTICALS, INC.. Filed 383 disclosures between FY2010 and FY2026 from worksites with a NY headquarters indicator.

Total filings
11
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of INVAGEN PHARMACEUTICALS, INC.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 97.1%, Cert-withdrawn 1.6%, Withdrawn 1.0%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified97.1%
Cert-withdrawn1.6%
Withdrawn1.0%
Denied0.3%
Certified97.1%
Cert-withdrawn1.6%
Withdrawn1.0%
Denied0.3%

Top occupations sponsored

SOC codes filed most by INVAGEN PHARMACEUTICALS, INC. across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY201020
FY201133
FY201257
FY201339
FY201420
FY201537
FY201620
FY201710
FY201826
FY201926
FY20202
FY202119
FY20224
FY20233
FY202420
FY202536
FY202611
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201020
FY201133
FY201257
FY201339
FY201420
FY201537
FY201620
FY201710
FY201826
FY201926
FY20202
FY202119
FY20224
FY20233
FY202420
FY202536
FY202611
Compare INVAGEN PHARMACEUTICALS, INC. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.